{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fidpodcast.simplecast.com%2Fepisodes%2Fhiv-monitoring-la-prep-79sBUlSG","width":444,"version":"1.0","type":"rich","title":"HIV Monitoring for People Receiving Long Acting PrEP","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/e017eb57-c367-47dd-bf98-8aa5064da367/6298-hiv-2024-contemporary-hiv-ll-3000x3000-1.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/6a4af3b9-bc43-4382-b2f1-7e011b0c7981\" height=\"200\" width=\"100%\" title=\"HIV Monitoring for People Receiving Long Acting PrEP\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Jonathan Appelbaum, MD, FACP, AAHIVS, discuss updated CDC guidance on why and how to monitor for HIV in people receiving LA PrEP."}